4th Quarter - Report

MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) for MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$176,300
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 18, 2018 $176,300 Replaced
4th Quarter - Amendment Jan 29, 2018 $176,300 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Provider related reimbursement issues and patient access issues

LobbyistCovered position, as disclosed
JOSEPH D ALVIANI —
AIMEE GOLBITZ —

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE; Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

Biomedical research funding and Medicare and Medicaid funding.

LobbyistCovered position, as disclosed
JOSEPH D ALVIANI —
AIMEE GOLBITZ —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Pharmacy PHA

Pricing, shortages, and safety issues

LobbyistCovered position, as disclosed
JOSEPH D ALVIANI —
AIMEE GOLBITZ —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH)

Health Issues HCR

All issues related to repeal and reform of the Affordable Care Act, prescription drug pricing,340B, laboratory developed test regulations, health care privacy legislation/regulations, human organ donations and allocations, Medicare reimbursement, telehealth reimbursement, mental health/substance use disorders, the common rule, and human subject protections.

LobbyistCovered position, as disclosed
JOSEPH D ALVIANI —
AIMEE GOLBITZ —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.